Authors:
ISMAIR MG
RIES C
LOTTSPEICH F
ZANG C
KOLB HJ
PETRIDES PE
Citation: Mg. Ismair et al., AUTOCRINE REGULATION OF MATRIX METALLOPROTEINASE-9 GENE-EXPRESSION AND SECRETION BY TUMOR-NECROSIS-FACTOR-ALPHA (TNF-ALPHA) IN NB4 LEUKEMIC-CELLS - SPECIFIC INVOLVEMENT OF TNF RECEPTOR-TYPE-1, Leukemia, 12(7), 1998, pp. 1136-1143
Authors:
FELDMAN EJ
SEITER K
DAMON L
LINKER C
RUGO H
RIES C
CASE DC
BEER M
AHMED T
Citation: Ej. Feldman et al., A RANDOMIZED TRIAL OF HIGH-DOSE VS STANDARD-DOSE MITOXANTRONE WITH CYTARABINE IN ELDERLY PATIENTS WITH ACUTE MYELOID-LEUKEMIA, Leukemia, 11(4), 1997, pp. 485-489
Authors:
PETRIDES PE
LOHER F
ISMAIR M
ZANG C
RIES C
Citation: Pe. Petrides et al., MATRIX METALLOPROTEINASES IN MONONUCLEAR-CELLS FROM THE BONE-MARROW OF 44 PATIENTS WITH ACUTE AND CHRONIC MYELOID-LEUKEMIA AND MYELODYSPLASTIC SYNDROMES, Experimental hematology, 25(8), 1997, pp. 439-439
Authors:
HOFMANN WK
KALINA U
WAGNER S
RIES C
HOELZER D
OTTMANN OG
Citation: Wk. Hofmann et al., CHARACTERIZATION OF DEFECTIVE IN-VITRO MEGAKARYOCYTIC DEVELOPMENT IN PATIENTS WITH MYELODYSPLASTIC SYNDROMES, Experimental hematology, 25(8), 1997, pp. 454-454
Authors:
DAMON L
RUGO H
WOLF J
BREED C
TRIPATHY D
RIES C
LINKER C
Citation: L. Damon et al., PULMONARY INJURY COMPLICATES THE ADDITION OF PACLITAXEL TO HIGH-DOSE ALKYLATORS AND STEM RESCUE IN PATIENTS WITH BREAST-CANCER, Blood, 90(10), 1997, pp. 4356-4356
Citation: H. Rugo et al., QUALITY-OF-LIFE EVALUATION FOLLOWING 4HC PURGED AUTOLOGOUS BONE-MARROW TRANSPLANT (ABMT) USING THE BUSULFAN ETOPOSIDE REGIMEN FOR ACUTE MYELOID-LEUKEMIA (AML)/, Blood, 90(10), 1997, pp. 1690-1690
Authors:
JORDAN D
TAFANI JAM
RIES C
ZAJAC JM
SIMONNET G
MARTIN D
KOPP N
ALLARD M
Citation: D. Jordan et al., EVIDENCE FOR MULTIPLE OPIOID RECEPTORS IN THE HUMAN POSTERIOR PITUITARY, Journal of neuroendocrinology, 8(11), 1996, pp. 883-887
Authors:
RIES C
LOTTSPEICH F
DITTMAN KH
PETRIDES PE
Citation: C. Ries et al., HL-60 LEUKEMIA-CELLS PRODUCE AN AUTOCATALYTICALLY TRUNCATED FORM OF MATRIX METALLOPROTEINASE-9 WITH IMPAIRED SENSITIVITY TO INHIBITION BY TISSUE INHIBITORS OF METALLOPROTEINASES, Leukemia, 10(9), 1996, pp. 1520-1526
Citation: Ae. Balantgorgia et al., METABOLIC INTERACTION BETWEEN FLUOXETINE AND CLOMIPRAMINE - A CASE-REPORT, Pharmacopsychiatry, 29(1), 1996, pp. 38-41
Authors:
PALMER CF
MCCAGUE R
RUECROFT G
SAVAGE S
TAYLOR SJC
RIES C
Citation: Cf. Palmer et al., UNEXPECTED STEREOSELECTIVITY IN THE CIS DIHYDROXYLATION OF SOME 2-CYCLOPENTENE-1-CARBOXAMIDES, Tetrahedron letters, 37(26), 1996, pp. 4601-4604
Authors:
JOHNSTON L
DAMON L
RIES C
RUGO H
LINKER C
Citation: L. Johnston et al., IDARUBICIN, HIGH-DOSE ETOPOSIDE AND HIGH-DOSE ARA-C (IDEA) TREATMENT OF HIGH-RISK ACUTE-LEUKEMIA - A RANDOMIZED STUDY OF SCHEDULE DEPENDENCY OF ETOPOSIDE, Blood, 88(10), 1996, pp. 855-855
Authors:
DITTMANN KH
LOTTSPEICH F
RIES C
PETRIDES PE
Citation: Kh. Dittmann et al., LEUKEMIC-CELLS (HL-60) PRODUCE A NOVEL EXTRACELLULAR MATRIX-DEGRADINGPROTEINASE THAT IS NOT INHIBITED BY TISSUE INHIBITORS OF MATRIX METALLOPROTEINASES (TIMPS), Experimental hematology, 23(2), 1995, pp. 155-160
Citation: C. Ries et Pe. Petrides, CYTOKINE REGULATION OF MATRIX METALLOPROTEINASE ACTIVITY AND ITS REGULATORY DYSFUNCTION IN DISEASE, Biological chemistry Hoppe-Seyler, 376(6), 1995, pp. 345-355
Citation: H. Rugo et al., SINGLE DAY LARGE-VOLUME LEUKAPHERESIS FOLLOWING STANDARD-DOSE CHEMOTHERAPY FOR BREAST-CANCER IS ADEQUATE FOR TRANSPLANTATION, Blood, 86(10), 1995, pp. 1618-1618
Citation: Pe. Petrides et C. Ries, REGULATION OF 92-KDA GELATINASE RELEASE IN HL-60 LEUKEMIA-CELLS - TUMOR-NECROSIS-FACTOR-ALPHA AS AN AUTOCRINE STIMULUS FOR BASAL AND PHORBOL ESTER-INDUCED SECRETION, Journal of cellular biochemistry, 1994, pp. 147-147
Authors:
ALLARD M
JORDAN D
ZAJAC JM
RIES C
MARTIN D
MONKOUANGA D
KOPP N
SIMONNET G
Citation: M. Allard et al., AUTORADIOGRAPHIC LOCALIZATION OF RECEPTORS FOR NEUROPEPTIDE FF, FLFQPQRFAMIDE, IN HUMAN SPINAL SENSORY SYSTEM, Brain research, 633(1-2), 1994, pp. 127-132
Citation: G. Smith et al., DOSE MODIFICATION REDUCES THE INCIDENCE OF HIGH-DOSE ARA-C (HDAC) NEUROTOXICITY IN PATIENTS WITH RENAL-INSUFFICIENCY, Blood, 84(10), 1994, pp. 10000146-10000146
Citation: H. Rugo et al., TREATMENT OF MYELODYSPLASTIC SYNDROMES (MDS) WITH SUBCUTANEOUS 5-AZACYTIDINE (AZA C), Blood, 84(10), 1994, pp. 10000317-10000317
Authors:
DAMON L
WOLF I
RUGO H
RIES C
TRACEY M
CECCHI G
GOLD E
LINKER C
Citation: L. Damon et al., AUTOLOGOUS BONE-MARROW TRANSPLANT (ABMT) FOR NON-HOGKINS (NHL) AND HODGKINS (HD) LYMPHOMA USING A THIOTEPA-BASED PREPARATIVE REGIMEN, Blood, 84(10), 1994, pp. 10000706-10000706
Citation: C. Ries et al., REGULATION OF 92-KD GELATINASE RELEASE IN HL-60 LEUKEMIA-CELLS - TUMOR-NECROSIS-FACTOR-ALPHA AS AN AUTOCRINE STIMULUS FOR BASAL-ESTER-INDUCE D AND PHORBOL-ESTER-INDUCED SECRETION, Blood, 83(12), 1994, pp. 3638-3646
Authors:
JORDAN D
ALLARD M
ZAJAC JM
RIES C
KOPP N
SIMONNET G
Citation: D. Jordan et al., AUTORADIOGRAPHIC LOCALIZATION OF F8FA RECEPTORS IN HUMAN SPINAL SENSORY SYSTEM, Neuropsychopharmacology, 9(2), 1993, pp. 190000160-190000161
Authors:
SCHOTT B
LONDOSGAGLIARDI D
RIES C
HUET S
ROBERT J
Citation: B. Schott et al., PHARMACOLOGICAL AND MOLECULAR CHARACTERIZATION OF INTRINSIC AND ACQUIRED DOXORUBICIN RESISTANCE IN MURINE TUMOR-CELL LINES, Journal of cancer research and clinical oncology, 119(9), 1993, pp. 527-532
Authors:
SCHOTT B
BENNIS S
POURQUIER P
RIES C
LONDOSGAGLIARDI D
ROBERT J
Citation: B. Schott et al., DIFFERENTIAL OVER-EXPRESSION OF MDR1 GENES IN MULTIDRUG-RESISTANT RATGLIOBLASTOMA CELL-LINES SELECTED WITH DOXORUBICIN OR VINCRISTINE, International journal of cancer, 55(1), 1993, pp. 115-121